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IMPACT OF A 90-DAY RETAIL PROGRAM ON PRESCRIPTION
DRUG EXPENDITURES
Sun SX, Lee K, Kleyn L, McMurray J, Fuldeore M, Bertram C
Walgreens Health Initiatives, Deerﬁeld, IL, USA
Advantage90TM allows patients to get maintenance medications
in 90-day supplies from a network of retail pharmacies. Before
the introduction of this program, medications in 90-day supplies
can only be purchased through mail. OBJECTIVES: This study
evaluated the impact of the program on prescription drug costs
and generic utilization. METHODS: Using pre-post cohort study
design, prescription records were obtained from Walgreens
Health Initiatives’ pharmacy claims database. For the purpose of
this study, specialty drugs were excluded. Clients were selected
if they had 3-tier formulary design and no mandatory mail
program, were rebate-eligible and continuously enrolled. The
study group comprised of 236,950 eligible lives from 17 clients
enrolled in Advantage90TM during January 1, 2004 and May 1,
2004, and the control group included 282,116 lives from 84
clients not enrolled in the program. The pre and post periods
were deﬁned as 8 months from the enrollment date. Per member
per month (PMPM) total costs and generic utilization were
analysed. RESULTS: There were no statistically signiﬁcant dif-
ference between the study and control group in terms of client
type, client region, and whether clients were enrolled in the ret-
rospective drug utilization review and other clinical programs.
From the pre to post period, in Advantage90TM group, PMPM
total costs and the percentage of generic utilization among eligi-
ble members increased by 1.93% (from $32.57 to $33.20) and
9.5% (from 40.1% to 43.9%). In the control group, PMPM 
total costs and the percentage of generic drug utilization
increased by 5.62% (from $36.30 to $38.34) and 7.9% (from
39.3% to 42.4%). Advantage90TM was estimated to have
resulted in a PMPM total cost savings of $1.20. CONCLU-
SIONS: A 90-day retail program like Advantage90TM led to
decreases in PMPM total costs and increases in generic utiliza-
tion on maintenance medications and can be an effective option
to lower drug costs.
PHP12
SOCIAL AND ECONOMIC FACTORS AFFECTING
INTENTIONAL PRESCRIPTION DRUG NON-COMPLIANCE
AMONG NOVA SCOTIA SENIORS
Okihiro NR, Davis N, MacRae H
Mount St.Vincent University, Halifax, NS, Canada
OBJECTIVES: To examine patterns of intentional prescription
drug non-compliance among seniors in Nova Scotia, Canada,
with special attention paid to social and economic factors.
METHODS: A survey was administered to 424 members of 
local seniors’ groups that were selected to ensure representation
from every county in Nova Scotia. The survey included sections
on health status, drug use, a battery of questions on non-
compliance, attitudes towards drug use-related issues and poli-
cies, and background information. Bivariate and multivariate
statistical techniques were employed, including factor analysis of
the non-compliance items. The quantitative analysis was sup-
ported by qualitative data from intensive interviews with 20
individual seniors. RESULTS: About one-quarter of the sample
had intentionally not followed a drug prescription in the 
past year. Factor analysis revealed two distinct types of non-
compliance, one related to not ﬁlling or reﬁlling a prescription,
and the other to adjusting or stretching a prescription. Income,
and variables related to marital status exerted direct effects on
non-compliance. Importantly, among those of lower income,
seniors who were not living with their spouses were much more
likely to intentionally not comply. There were also gender dif-
ferences in the relationship among social factors, economic
factors and non-compliance. The qualitative data supported the
general ﬁnding that some seniors are adamant about taking
control of their own health, including making decisions not to
follow a doctor’s prescription. CONCLUSIONS: In a province
with a government-subsidized seniors drug care program, a sub-
stantial minority of seniors intentionally decided not to comply
with a drug prescription. Social factors, economic factors 
and gender were found to interact in a complex way to affect
intentional non-compliance. Among some respondents, non-
compliance is related to attempts to take more control over their
own health.
PHP13
TRENDS IN THE PREVALENCE OF INAPPROPRIATE
PRESCRIBING AMONG ELDERLY MEDICARE BENEFICIARIES,
1992–2001
Mahmood M1, Craig BM1, Ko Y1,Armstrong EP2
1University of Arizona,Tucson, AZ, USA; 2University of Arizona
College of Pharmacy,Tucson, AZ, USA
OBJECTIVES: 1) Isolate trends in the prevalence of inappropri-
ate prescribing among elderly Medicare beneﬁciaries; 2) deter-
mine which inappropriate medicines are the most commonly
prescribed; and 3) identify the relationship between inappropri-
ate prescribing and drug coverage. METHODS: Using 10 years
of prescribed medicine event (PME) data from the Cost and 
Use component of the Medicare Beneﬁciary Survey (MCBS)
1992–2001, we estimated the weighted prevalence of inappro-
priate prescribing, based on Beer’s Criteria, among elderly 
beneﬁciaries. The MCBS is a longitudinal survey; therefore par-
ticipant may contribute multiple years of PME data. These data
were stratiﬁed by year and chi-squared tests on differences in
inappropriate prescribing by drug coverage were conducted to
address the hypothesis that Medicare Part D may increase the
prevalence of inappropriate prescribing by reducing economic
barriers to access. RESULTS: Among the 94,372 person-years of
data, 31.8% reported inappropriate prescribing. From 1992 
to 2001, the weighted prevalence of inappropriate prescribing
ranged from 30.2% in 2001 to 33.8% in 1993. The three 
most common inappropriate medications were propoxyphene
(7.0%), naproxen (3.6%), and amitriptyline (3.1%), but their
prevalence varied greatly by year. Drug coverage was positively
associated with inappropriate prescribing in each year. CON-
CLUSION: The ﬁndings suggest that inappropriate prescribing
remains prevalent in geriatric care. The fact that there was 
no signiﬁcant decline in inappropriate prescribing highlights 
the importance of adapting more effective policy measures to
improve prescribing patterns in geriatric patients. The ﬁndings
also suggest that drug coverage was associated with higher
prevalence of inappropriate prescribing probably caused by
increase access to care.
PHP14
MAKING A CASE FOR EMPLOYING SOCIETAL PERSPECTIVE
IN THE EVALUATION OF MEDICAID FORMULARIES
Roy S, Madhavan SS
West Virginia University, Morgantown, WV, USA
OBJECTIVE: Publicly funded Medicaid prescription drug
expenditures continue to escalate at rates far greater than those
of private insurance programs. Cost containment policies like
formularies or PDLs have been implemented widely to stem such
growth. While a payer perspective is justiﬁed in evaluating the
budgetary and program impact of formularies in private payer
programs, a societal perspective is more appropriate in public
287Abstracts
funded programs like Medicaid. Objective of this study was to
review published studies that evaluate the impact of Medicaid
formularies, and to assess the perspective that was adopted 
for such evaluations. METHODS: Searches were performed in
several scientiﬁc and business databases along with other rele-
vant health policy journals and websites. The search strategy
involved an incremental focus using a tiered approach, narrow-
ing search returns down to the speciﬁc inclusion criteria with
multiple combinations of search terms. Selected articles were
reviewed to assess the perspective adopted based on key mea-
surement parameters used in evaluation of the impact.
RESULTS: Twenty studies were selected for the review. All
studies used a pre-post or a time-series research design. Three
studies utilized pooled multi-state data, two studies included a
second state’s Medicaid population as a control group, and the
remaining were studies of single state Medicaid populations. 
All studies evaluated direct impacts of a formulary strategy on
drug and program costs. Three studies additionally investigated
broader second order effects on physician, outpatient and hos-
pital utilization. None of the evaluations included estimates of
indirect costs related to the positive or negative impact of for-
mularies on morbidity, mortality and consequent productivity of
Medicaid beneﬁciaries. Therefore, the true impact of formularies
in these evaluations remain unclear. CONCLUSION: Findings of
the literature review of Medicaid formulary evaluations suggest
that such a societal perspective has not been widely adopted, and
can be a valuable option for future evaluations.
PHP15
PHARMACOECONOMIC EDUCATION AT MEDICAL SCHOOLS
IN TURKEY
Tulunay F, Gulmez S, Ergun H
Ankara University School of Medicine, Ankara,Turkey
OBJECTIVE: There is an increasing interest in pharmacoeco-
nomics among physicians. However, as can be seen from multi-
ple examples, the concept is prone for abuse and misuse. In this
study we evaluated the curriculum of the Turkish medical
schools. We looked at whether they have any formal pharma-
coeconomic lectures or they are planning on introducing phar-
macoecononmics lectures within the pharmacology, clinical
pharmacology or other courses. METHODS: A questionnaire
was prepared to evaluate the pharmacoeconomics education at
35 Medical Schools in Turkey. We got in contact with the head
of the Pharmacology Departments either by phone or by face to
face interviews. The questionnaire was composed of questions
regarding the presence of pharmacoeconomics lectures; i.e. if
already in curriculum, at which year, and for how many hours.
If no pharmacoeconomics lecture exists, is there any intention of
including it in the curriculum. RESULTS: We got replies from 27
(77%) of the Pharmacology Departments. Pharmacoeconomy
lecture is currently given only at two niversities (Ankara,
Atatürk). All but two of the other departments communicated
that pharmacoeconomics lectures will be given in the future.
CONCLUSION: Pharmacoeconomics is an important part of
clinical pharmacology. However the concept is not part of the
medical school curriculum in most universities. There is a trend
towards giving pharmacoeconomics classes at fourth or ﬁfth year
within clinical pharmacology lectures. Even though most of the
pharmacology departments informed that they are going to
include pharmacoeconomics into the curriculum, currently prac-
ticing physicians lack the necessary knowledge. In our opinion,
in addition to the inclusion of pharmacoeconomics in the
medical school curriculums, special programs are also required
for physicians who had not had a formal pharmacoeconomic
course during their undergraduate education. There is an increas-
ing responsibility for pharmacology/clinical pharmacology
departments to take a role in such programs.
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ADVERTISING IN RESPONSE TO NEW PRODUCT ENTRY:
AN EXAMINATION OF THE STRATEGIC ROLE OF
PHARMACEUTICAL ADVERTISING ON MARKET
COMPETITION
Kwong WJ1, Norton EC2
1GlaxoSmithKline Research and Development, Research Triangle Park,
NC, USA; 2The University of North Carolina at Chapel Hill, Chapel
Hill, NC, USA
OBJECTIVE: Industrial organization economics theory sug-
gested ﬁrms may over- or under-advertise to deter or accommo-
date entry depending on how advertising affects the proﬁts of
competitors, and if the competing products are strategic substi-
tutes or complements. The objective of this study was to deter-
mine if this theory holds for pharmaceutical products. Such
information would increase policy makers’ understanding of
how advertising affects competition when considering advertis-
ing regulations. METHODS: Data on products for eight therapy
areas (asthma, migraine, obesity, Parkinson’s disease, seizure,
depression, dyslipidemia, and gastric and duodenal ulcer) from
January, 1995 to December, 2001 were analyzed on a quarterly
basis. Multivariate analyses were performed to examine the
strategic relationship between advertising expenditures and
product sales. Changes in an existing product’s advertising
expenditure in the period after new product entry were exam-
ined using time-disease ﬁxed-effects regression, by controlling for
the type of new entrants (the presence of creative entrants, uncre-
ative entrants or both in the same period), patent life, and market
share. Creative entrants were new products with novel pharma-
cological mechanisms of action that were different from that of
existing products. Uncreative entrants included me-too drugs
and generic products. Advertising expenditure and sales data
were obtained from Scott-Levin Market Research Audit. Patent
and product entry information were from published references.
RESULTS: Multivariate analyses showed competing pharma-
ceutical products were strategic complements and sales of new
entrants increased with existing product’s advertising expendi-
ture, although these relationships were not statistically signiﬁ-
cant. There were no statistically signiﬁcant changes in advertising
expenditure in response to any types of new product entry. CON-
CLUSION: The strategic effect of advertising on market com-
petitiveness was weak and not signiﬁcant. No evidence was
found that pharmaceutical ﬁrms would use advertising as a
strategic tool to deter or accommodate entry. These results did
not support regulating pharmaceutical advertising based on anti-
competitive grounds.
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MODELING THE COST AND UTILIZATION OF MAIL ORDER
VS. COMMUNITY PHARMACY IN A MEDICAID POPULATION
Valluri SC, Rodriguez-Monguio R, Seoane-Vazquez EC
Ohio State University, Columbus, OH, USA
OBJECTIVES: To model the effect of mail order vs. community
pharmacy on drug utilization and drug product cost in a 
Medicaid population. METHODS: Drug treatments initiated
between August, 2000 and July, 2001 were retrieved. Drug treat-
ments with at least two claims and 60 days of supply, and an
adherence ratio of 0.5 were included in the study. In the base-
line scenario, utilization in mail order was modeled using the uti-
lization in community pharmacy, and assuming that the ﬁrst
prescription was dispensed in community pharmacy, and suc-
cessive prescriptions were dispensed as 90-day supply in mail
